New! A group of medical equipment company, won the national award

Pharmaceutical Network December 22 hearing Recently, the State Intellectual Property Office issued a notice confirming the 2017 national intellectual property demonstration enterprises and superior enterprises.

According to incomplete statistics, a total of 103 pharmaceutical companies on the list, the Yangtze River, Chia Tai Teng, Jiuzhitang, Jimin credible, Kang Mei, Qilu and other well-known pharmaceutical companies, and Shanghai minimally invasive, Huada gene, Shenyang Neusoft, IVD companies - Viagra biological, Zhejiang Kehui, Zhuhai Jian sail, Jiangxi Taifook, Guan Hao bio-machinery industry companies are on the list.

It is learned that the list of national IPR demonstration enterprises and advantageous enterprises issued by the State Intellectual Property Office is based on the lists submitted by the IP offices of each province mainly for the purpose of further developing the national IPR demonstration enterprises and the national IPR advantageous enterprises, Realization of strong intellectual property development goals.

1, pilot enterprises at all levels of intellectual property pilot, high-tech enterprises or provincial-level enterprise technology center relying on the enterprise.

2. Have a clear development strategy of intellectual property and sound management system, incentive mechanism and training mechanism of intellectual property rights; set up an intellectual property management institution in charge of principal responsible persons of the enterprise, and have declared more than 1 intellectual property commissioner and set up special funds for intellectual property work ; The training rate of intellectual property of enterprise managers and R & D personnel has reached more than 80%, and the training rate of intellectual property of general staffs has reached more than 60%.

3, the first three years of the reporting year (data is limited to 2014 to 2016) a total of 15 patents, of which more than 3 invention patents; at the same time have been granted more than 5 patents, including invention patents 1 or more.

4, nearly three fiscal years, annual research and development investment accounted for more than 3% of annual sales.

5, in line with the direction of industrial development, with independent intellectual property rights and industrialization, declare the first three years to maintain profitability.

6. To establish a mechanism for the protection and early-warning of intellectual property rights so as to better protect its own intellectual property rights. There are no acts allegedly infringing the intellectual property rights of others in the first three years of the reporting year and being finalized through administrative or judicial final approval.

With 61 in 2016 medicine enterprise Compared to the list, the number of pharmaceutical companies listed in 2017 increased significantly, more than the previous year 42. This shows that pharmaceutical companies have a considerable innovation and R & D capacity growth.

Of the 103 pharmaceutical companies listed, 23 enterprises were selected as the 2017 national intellectual property demonstration enterprises and 80 enterprises were selected as the 2017 national intellectual property preferential enterprises with a term from December 2017 to November 2020.